Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients.

Lindsey K Greenlund Claire HerzogZachary WendlandKatelyn RypkaJohn W FrewJoslyn S KirbyAfsaneh AlaviBisma KhalidMichelle A LowesAmit Garg Angelo Valerio Marzano Christos C ZouboulisThrasyvoulos TzellosTarannum JaleelNoah Goldfarb

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)

The result of the current study reaffirms the gap in how providers characterize and count HS lesions for clinical trials and the need to develop consensus-driven rater training related to HS outcome measures.

Keyphrases

clinical trial
end stage renal disease
hidradenitis suppurativa
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
clinical practice
patient reported
open label